Navigation Links
Quantitative Analysis of Biomarkers, New Life Science Webinar Hosted by Xtalks
Date:6/17/2013

Toronto, Canada (PRWEB) June 17, 2013

As interest increases in developing novel biomarker and biotherapeutic assays to support clinical development, so does the need to keep up with the pace of new discoveries and evolving fit-for-purpose methods.

This webinar, the first in a series titled “Better Methods for Novel Biomarkers” exploring approaches to improving biomarker analysis across a range of technologies, introduces a novel method for more definitive quantification of circulating levels of peptides and proteins than either ELISA or traditional LCMS can achieve.

In addition to learning how to achieve the sensitivity of ELISA with the specificity of LCMS, participants in this complimentary webinar will:

  • Learn how immunoprecipitation methodologies of ELISA can be incorporated with nanoLC/MS to achieve sensitivity that is comparable to ELISA but with the specificity of LCMS
  • View new techniques that can be implemented to address robustness issues associated with nanoLC/MS
  • Review validated methods where a lower limit of quantification (LLOQ) comparable or better than current ELISA assays was achieved

To learn more about the event, visit:

http://xtalks.com/Quantitative-Analysis-of-Biomarkers.ashx

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/6/prweb10835915.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Rigaku Announces Method for Quantitative Elemental Analysis of Low-Alloy Steel with the Rigaku ZSX Primus III+ WDXRF Spectrometer
2. Rigku Publishes New Method for Quantitative Analysis of Cast Iron Using the ZSX Primus III+
3. Rigaku Publishes New Application Note for Quantitative Analysis of Stainless Steel
4. Rigaku Publishes Application Note for Accurate Quantitative Analysis of Ferrosilicon by the Fusion Method Using ZSX Primus III+
5. USDA/GIPSA Approves Charm Sciences’ ROSA® FAST Aflatoxin Quantitative Test
6. Neogen Launches Fully Quantitative Lateral Flow Test for DON
7. Rigaku Publishes New Application Note for EDXRF Analysis of Major Oxides in Finished Cement
8. Global Catalysts Industry 2013-2018: Trend, Profit, and Forecast Analysis - Benchmark the Worlds Top 5 Drug Companies
9. RIGAKU Publishes New Method for EDXRF Analysis of Precious Metals in Recycled Automotive Catalytic Converters
10. Rigaku Introduces the Fastest 1D Detector for XRD Analysis
11. Global Bioabsorbable Stents Market - Market Analysis and Forecasts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):